• ABPI Website
  • Media
  • ABPI response to EU transparency mechanism for COVID-19 vaccines exports

ABPI response to EU transparency mechanism for COVID-19 vaccines exports

29 January 2021 Posted in News by Press Office

The European Commission has announced a transparency and authorisation mechanism for exports of COVID-19 vaccines.

Companies are working as fast as they can to scale up supply for everyone around the world.  Restrictions will slow this progress and we urge all Governments to avoid them. Richard Torbett

In response Richard Torbett, Chief Executive of the Association of the British Pharmaceutical Industry, said:

“Introducing any kind of export restrictions on manufacturers distributing COVID19 vaccines means we are trying to fight the pandemic with our hands tied behind our backs.

“Global supply chains are absolutely vital – whether for moving around components of medicines and vaccines or finished products – and they must be allowed to operate unimpeded.

“Companies are working as fast as they can to scale up supply for everyone around the world. Restrictions will slow this progress and we urge all Governments to avoid them.”

TAGS
  • COVID 19

Last modified: 20 September 2023

Last reviewed: 20 September 2023

The ABPI exists to make the UK the best place in the world to research, develop and use new medicines. We represent companies of all sizes who invest in discovering the medicines of the future. 

Our members supply cutting edge treatments that improve and save the lives of millions of people. We work in partnership with Government and the NHS so patients can get new treatments faster and the NHS can plan how much it spends on medicines. Every day, we partner with organisations in the life sciences community and beyond to transform lives across the UK.

Media enquiries

+44 (0) 20 7747 7147​​